# Erythropoietin for Management of Anemia Caused by Chemotherapy

> **NCT02890602** · PHASE2 · COMPLETED · sponsor: **Kosin University Gospel Hospital** · enrollment: 53 (actual)

## Conditions studied

- Diffuse Large B-cell Lymphoma

## Interventions

- **DRUG:** Darbepoetin alfa
- **DRUG:** R-CHOP

## Key facts

- **NCT ID:** NCT02890602
- **Lead sponsor:** Kosin University Gospel Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09-01
- **Primary completion:** 2017-11-28
- **Final completion:** 2017-12-07
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02890602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02890602, "Erythropoietin for Management of Anemia Caused by Chemotherapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02890602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*